Concepedia

Todd Herbst

TH

Statistics

Publications

9

Citations

327

H-Index

9

Active since

1999

Affiliations

IRBM Science Park(Current)

CHDI Foundation

Evotec (Germany)

Karolinska Institutet

Cortex Pharmaceuticals (United States)

Todd Herbst is an author at IRBM Science Park specializing in neuroscience, medicine, and ligand binding.

Publications per year

1999–2022

9

Publications

9

Synergistic Interactions between Ampakines and Antipsychotic Drugs

Steve A. Johnson, Todd Herbst, Richard J. Knapp et al. · Journal of Pharmacology and Experimental Therapeutics · 1999 · 85 citations

Medicine, Neuroscience, Pharmacology +17

Imaging Mutant Huntingtin Aggregates: Development of a Potential PET Ligand

Longbin Liu, Michael E. Prime, Matt R. Lee et al. · Journal of Medicinal Chemistry · 2020 · 56 citations

Medicine, Neuroscience, Nuclear Medicine +17

Establishment of an in Vitro Human Blood-Brain Barrier Model Derived from Induced Pluripotent Stem Cells and Comparison to a Porcine Cell-Based System

Annalise Di Marco, Domenico Vignone, Odalys Gonzalez Paz et al. · Cells · 2020 · 41 citations · Full text

Life Sciences, Bioengineering, Neuroscience +14

Application of an in Vitro Blood–Brain Barrier Model in the Selection of Experimental Drug Candidates for the Treatment of Huntington’s Disease

Annalise Di Marco, Odalys Gonzalez Paz, Ivan Fini et al. · Molecular Pharmaceutics · 2019 · 40 citations

Pharmacy, Neuroscience, Pharmacology +17

[<sup>11</sup>C]CHDI-626, a PET Tracer Candidate for Imaging Mutant Huntingtin Aggregates with Reduced Binding to AD Pathological Proteins

Longbin Liu, Peter Johnson, Michael E. Prime et al. · Journal of Medicinal Chemistry · 2021 · 31 citations

Life Sciences, Neurology, Neuroscience +17

1–5 of 9